Raiffeisen Bank International Ag Sarepta Therapeutics, Inc. Put Options Transaction History
Raiffeisen Bank International Ag
- $6.27 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
506Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$413 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$362 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$361 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$163 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$135 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.5B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...